Stock data
Novartis$105.85
NOVN 
0.65% • 24 H
0.65% • 24 HDividend Yield:3.3%
Global Rank#48
Market Cap$217.57B
YTD Performance9.70%
P/E0
Revenue$46.66B
Change 7d4.57%
SP500 BenchmarkUnderperform
Country🇨🇭 Switzerland
P/S4.66
Earnings$14.85B
Dividend Yield:3.3%
Main Sector
Healthcare
Novartis (NOVN) Total Liabilities
NOVN Total Liabilities in 2022: $53.20B
According to Novartis latest financial reports the total liabilities of NOVN is $53.20B, an decrease of -8.33% to 2022. At the end of 2022 company had $58.03B total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Novartis is responsible for during its operational activities.
Novartis (NOVN) Total Liabilities History from 2023 to 2022
-
Value:-
NOVN Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $53.20B | -8.33% |
| 2022 | $58.03B | -9.29% |
| 2021 | $63.97B | -10.04% |
| 2020 | $71.11B | 13.20% |
| 2019 | $62.82B | 58.32% |
| 2018 | $39.68B | - |
View the Top Total Liabilies Stocks
